133 completed, 36 terminated, 29 recruiting, 25 active not recruiting. 92 Phase 2, 81 Not applicable, 50 Phase 1, 8 Early Phase 1, 8 Phase 3.
Follow Fox Chase Cancer Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer Non Small Cell Lung Cancer | Not yet recruiting | Fox Chase Cancer Center | 200 | 2026-10-06 | 2026-10-02 | |
| Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy Mycophenolate Mofetil plus prednisone - Immune-mediated Hepatitis, Immune-related Adverse Event | Phase 2 | Recruiting | Fox Chase Cancer Center | 31 | 2026-07-23 | 2026-09-17 |
| Prehabilitation in High-risk Oncologic Surgery Multidisciplinary Prehabilitation Program - Pancreatic Cancer, Colo-rectal Cancer | Not applicable | Recruiting | Fox Chase Cancer Center | 180 | 2026-07-15 | 2026-09-21 |
| Genetic Information for Families After Tumor Testing Study Interactive Chatbot - Cancer | Not applicable | Enrolling by invitation | Abramson Cancer Center at Penn Medicine | 100 | 2026-07-15 | 2026-07-29 |
| Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) Digital Endocrine therapy Symptom Monitoring and Education Intervention - Cancer | Not applicable | Recruiting | Abramson Cancer Center at Penn Medicine | 60 | 2026-05-13 | 2026-06-12 |
| Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas intradermal injection of CADI-05, Pembrolizumab - Squamous Cell Carcinoma of Head and Neck | Phase 1 | Recruiting | Fox Chase Cancer Center | 22 | 2026-04-08 | 2026-04-15 |
| A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery Post radical prostatectomy nerve restoration procedure (PRP-NR) - Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy | Not applicable | Recruiting | Sir Mortimer B. Davis - Jewish General Hospital | 100 | 2026-01-30 | 2026-03-10 |
| Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma Enfortumab vedotin, Pembrolizumab - Metastatic Urothelial Carcinoma, Unresectable Urothelial Carcinoma | Phase 2 | Recruiting | Fox Chase Cancer Center | 97 | 2026-01-23 | 2026-02-19 |
| Adaptive Radiation Boost for Rectal Cancer Adaptive Radiotherapy Boost - Rectum Cancer, Adenocarcinoma | Phase 1 | Recruiting | Fox Chase Cancer Center | 37 | 2025-10-24 | 2025-12-09 |
| Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy Cannabidiol (CBD), oxaliplatin-based chemotherapy - Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC) | Early Phase 1 | Recruiting | Fox Chase Cancer Center | 30 | 2025-10-14 | 2025-10-22 |
| Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer adaptive stereotactic body radiation therapy (SBRT) with a SIB - Prostate Cancer (Adenocarcinoma) | Not applicable | Recruiting | Fox Chase Cancer Center | 80 | 2025-09-25 | 2025-10-29 |
| Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) Cancer | Recruiting | Abramson Cancer Center at Penn Medicine | 360 | 2025-09-02 | 2026-03-13 | |
| Tumor Rupture During Robotic Partial Nephrectomy robot-assisted partial nephrectomy - Kidney Cancer, Renal Neoplasms | Not yet recruiting | Azienda Ospedaliera Universitaria Integrata Verona | 100 | 2025-09-01 | 2025-07-15 | |
| Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients Indirect Calorimeter, Weight-Based Parenteral Nutrition Dosing - Malnutitrion, Cancer | Not applicable | Recruiting | Fox Chase Cancer Center | 50 | 2025-08-21 | 2026-08-20 |
| Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer Adaptive Radiation Therapy - Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA) | Not applicable | Recruiting | Fox Chase Cancer Center | 16 | 2025-08-20 | 2025-10-29 |
| Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma Gemcitabine, Carboplatin - Urothelial Carcinoma | Phase 2 | Recruiting | Fox Chase Cancer Center | 55 | 2025-07-09 | 2026-09-17 |
| MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma Bendamustine, Rituximab - Lymphoma, Indolent Non-hodgkin Lymphoma | Phase 2 | Not yet recruiting | Fox Chase Cancer Center | 24 | 2025-06-01 | 2025-01-06 |
| Testing Gene PilotLX With Latinx Cancer Patients Gene PilotLX - Cancer | Not applicable | Active not recruiting | Fox Chase Cancer Center | 239 | 2025-05-30 | 2026-09-02 |
| Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy. Scrambler Therapy, Questionnaire and Physical Exam - CIPN - Chemotherapy-Induced Peripheral Neuropathy, Pain | Phase 2 | Recruiting | Fox Chase Cancer Center | 50 | 2025-03-03 | 2025-04-09 |
| Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning. Cancer care delivery - Care Delivery, Geriatrics | Not applicable | Recruiting | Fox Chase Cancer Center | 100 | 2025-02-21 | 2026-09-21 |
Showing 20 of 255. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (22) · Neoplasms (21) · Prostatic Neoplasms (20) · Breast Neoplasms (19) · Lung Neoplasms (19) · Rectal Neoplasms (18) · Colorectal Neoplasms (17) · Colonic Neoplasms (14) · Pancreatic Neoplasms (12) · Lymphoma (9) · Carcinoma, Transitional Cell (8) · Head and Neck Neoplasms (8) · Urinary Bladder Neoplasms (8) · Esophageal Neoplasms (7) · Squamous Cell Carcinoma of Head and Neck (7)
Paclitaxel (20) · Carboplatin (19) · Radiotherapy (17) · Cisplatin (10) · Gemcitabine (10) · pembrolizumab (10) · Nivolumab (8) · Counseling (7) · Cyclophosphamide (7) · Filgrastim (7) · Fluorouracil (7) · Peripheral Blood Stem Cell Transplantation (7) · Cetuximab (6) · Bevacizumab (5) · Capecitabine (5)
United States (241) · Canada (2) · Italy (2) · Austria (1) · Belgium (1) · France (1) · Germany (1) · Netherlands (1) · Norway (1) · Poland (1) · Spain (1)
Corey J. Langer, MD (8) · Joshua Meyer, MD (7) · Hossein Borghaei, DO (5) · Margaret von Mehren, MD (5) · Russell J. Schilder, MD (4) · Angela Bradbury, MD (3) · Carolyn Fang, PhD (3) · David Weinberg, MD, MSC (3) · Gary R. Hudes, MD (3) · Gina Martina-Smaldone, MD (3) · Joshua Meyer (3) · Matthew Zibelman, MD (3) · Mitchell R. Smith, MD, PhD (3) · Namrata Vijayvergia, MD (3) · Neal J. Meropol, MD (3)
PMID 38865671, PMID 17410043, PMID 18988231, PMID 19833819, PMID 20035187, PMID 20142594, PMID 20347506, PMID 20458210, PMID 20593535, PMID 20828635, PMID 21090893, PMID 21212064, PMID 21338483, PMID 21994964, PMID 22294255, PMID 22518350, PMID 22927525, PMID 23128366, PMID 23620404, PMID 24047116, PMID 24101042, PMID 24611691, PMID 24821881, PMID 25242854, PMID 25329201, PMID 25371447, PMID 26041651, PMID 26091915, PMID 26174168, PMID 26810358, PMID 27197299, PMID 27371698, PMID 27819460, PMID 27869293, PMID 29174927, PMID 29444707, PMID 29587805, PMID 29802491, PMID 30333221, PMID 30338661, PMID 30431292, PMID 30745365, PMID 31029646, PMID 31285713, PMID 31531798, PMID 32051002, PMID 32119599, PMID 32152503, PMID 32250730, PMID 33384959
P30CA006927 (40), 2015 (2), K07CA108685 (1), K08CA279076 (1), P30CA008748 (1), P30CA044579 (1), R00CA267678 (1), R01CA078084 (1), R01CA102695 (1), R01CA104670 (1), R01CA104979 (1), R01CA109332 (1), R01CA125069 (1), R01CA154928 (1), R01CA158019 (1)